The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Reveals Lupus Is a Leading Cause of Death in U.S. Women

Study Reveals Lupus Is a Leading Cause of Death in U.S. Women

October 18, 2018 • By Kimberly J. Retzlaff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Chinnapong / shutterstock.com

Chinnapong / shutterstock.com

Systemic lupus erythematosus (SLE) is a leading cause of death among young women, according to an August 2018 study in Arthritis & Rheumatology.1 To help determine where SLE ranks among causes of death, Eric Y. Yen, MD, and Ram Raj Singh, MD, conducted a population-based study using nationwide mortality counts for all female residents of the U.S. from 2000 to 2015. They concluded that SLE is an important public health issue among young women and that ongoing research and education are needed to address it.

You Might Also Like
  • SLE Is a Leading Cause of Death Among Women
  • A 46-Year Study Traces the Lupus Death Rate from 1968–2013
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
Explore This Issue
October 2018

Research Objective

“During my medical training in pediatrics, I noticed that lupus is a common disease that I see on the wards,” says Dr. Yen, assistant professor, Department of Medicine, University of California, Los Angeles (UCLA). “So when I joined the pediatric rheumatology fellowship at UCLA, I set out to determine SLE death rates.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“To our dismay, we found the death rates for SLE were disproportionately high relative to death rates in the general population. … This finding led us to posit that SLE might be among the leading causes of death,” explains Dr. Singh, professor of medicine and pathology, and director of the Auto­immunity and Tolerance Laboratory, UCLA.

Previously, Drs. Yen and Singh, along with several others, conducted a multiple-regression analysis of SLE mortality risk stratified by race and ethnicity, which was published in the Annals of Internal Medicine in 2017. The analysis showed that SLE mortality risk was higher for women than men of all races and ethnicities, with the greatest differences among black and Hispanic patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Yen also noticed that SLE was not included in the 113 diseases on the Centers for Disease Control and Prevention’s (CDC’s) ranked list of leading causes of death. “Given my suspicion that SLE was more common than some of the other diseases on the CDC list, I decided to take on this project,” he says of the current research.

Study Methods & Results

Drs. Yen and Singh conducted a population-based study using nationwide mortality counts for U.S. girls and women. They obtained data on SLE deaths from the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) database. They attributed deaths to SLE if codes from the International Classification of Diseases, 10th revision (ICD-10), for SLE were listed as an underlying or contributing cause of death on the death certificate: M32.1, SLE with organ or system involvement; M32.8, other forms of SLE; and M32.9, SLE, unspecified.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: death rate, Gender, mortality rate, Rheumatology Research FoundationIssue: October 2018

You Might Also Like:
  • SLE Is a Leading Cause of Death Among Women
  • A 46-Year Study Traces the Lupus Death Rate from 1968–2013
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
  • New Study Reveals Limitations in ANA Test Kits for Lupus

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)